BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Stem cell
,
Pharmacogenetics
,
Doxorubicin
,
rs4950928
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Polycomb
Summary
General Info
Curated Studies
Most Correlated Studies
Embryonic carcinoma NCCIT cells depleted of MLL/COMPASS and Polycomb complexes
Embryonic stem cells depleted of the Polycomb group family member Cbx7
Polycomb group protein Suz12 iin embryonic stem cell differentiation
The effects of PTIP on Polycomb mediated repression in Drosophila Kc167 cells.
Polycomb gene knockdown in Drosophila S2 embryonic cell line
Explore Curated Studies Results
Literature
Most Relevant Literature
Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Car…
Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes.
Cuproptosis-related ceRNA axis triggers cell proliferation and cell cycle through CBX2 in lung adeno…
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma ce…
Bioinformatics analysis reveals that CBX2 promotes enzalutamide resistance in prostate cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A…
Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-…
RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Rem…
EZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ